Brief: Avadel Pharmaceuticals Says Delaware District Court Denied Request By Jazz Pharma On Permanent Injunction To Enjoin Co's Unit From Selling LUMRYZ

Avadel Pharmaceuticals

28/08/2024 13:12

Aug 28 (Reuters) - Avadel Pharmaceuticals PLC  AVDL.O :
    * AVADEL PHARMACEUTICALS: DELAWARE DISTRICT COURT DENIED
REQUEST
BY JAZZ PHARMA ON PERMANENT INJUNCTION TO ENJOIN CO'S UNIT FROM
SELLING LUMRYZ
    * AVADEL PHARMACEUTICALS: COURT GRANTED JAZZ’S REQUEST
PREVENTING
UNIT FROM SEEKING FDA APPROVAL FOR USE/MARKET LUMRYZ TO TREAT
IDIOPATHIC HYPERSOMNIA
    * AVADEL PHARMACEUTICALS: DISAGREES WITH COURT’S DECISION ON
IDIOPATHIC HYPERSOMNIA AND HAS FILED NOTICE OF APPEAL
    * AVADEL PHARMACEUTICALS: CONTINUES TO INVEST IN DEVELOPMENT
OF
LUMRYZ FOR IH

Source text for Eikon:  ID:n0001104659-24-093714 
Further company coverage:  AVDL.O 

 ((Reuters.Briefs@thomsonreuters.com;))